We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
AUM
$691K
AUM Growth
+$78K
Cap. Flow
+$226M
Cap. Flow %
32,646.26%
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53

Sector Composition

Rank Sector Weight
1 Energy 28.66%
2 Technology 9.15%
3 Healthcare 7.9%
4 Financials 6.09%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
1
Kinder Morgan
KMI
$71.9B
$182K 26.36%
15,719
+11,967
+319% +$182K
XLE icon
2
State Street Energy Select Sector SPDR ETF
XLE
$38.2B
$18.6K 2.69%
1,062,396
-174,300
-14% -$3.24M
XOP icon
3
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.48B
$15.6K 2.26%
+330,906
New +$16.7M
PALL icon
4
abrdn Physical Palladium Shares ETF
PALL
$602M
$12.4K 1.8%
+340
New +$12.7K
GLD icon
5
SPDR Gold Trust
GLD
$130B
$9.83K 1.42%
58,751
+58,162
+9,875% +$9.38M
MSFT icon
6
Microsoft
MSFT
$2.93T
$9.35K 1.35%
46,003
-18,268
-28% -$3.32M
QCOM icon
7
Qualcomm
QCOM
$181B
$9.31K 1.35%
2,180
+25
+1% +$2K
AAPL icon
8
Apple
AAPL
$4.9T
$8.94K 1.29%
98,028
-23,108
-19% -$1.79M
BSV icon
9
Vanguard Short-Term Bond ETF
BSV
$44.7B
$8.77K 1.27%
100,398
+36,670
+58% +$3.03M
GILD icon
10
Gilead Sciences
GILD
$167B
$8.66K 1.25%
112,583
-23,073
-17% -$1.77M
CVS icon
11
CVS Health
CVS
$137B
$7.97K 1.15%
122,712
-146
-0.1% -$9.19K
PFE icon
12
Pfizer
PFE
$143B
$7.13K 1.03%
229,664
+3,886
+2% +$132K
SGOL icon
13
abrdn Physical Gold Shares ETF
SGOL
$6.85B
$6.7K 0.97%
390,823
+90,939
+30% +$1.5M
VEA icon
14
Vanguard FTSE Developed Markets ETF
VEA
$226B
$6.21K 0.9%
160,144
+146,541
+1,077% +$5.35M
VIG icon
15
Vanguard Dividend Appreciation ETF
VIG
$111B
$6.13K 0.89%
52,292
+50,882
+3,609% +$5.79M
VO icon
16
Vanguard Mid-Cap ETF
VO
$106B
$6.1K 0.88%
178,964
+75,668
+73% +$2.9M
BAC icon
17
Bank of America
BAC
$430B
$5.88K 0.85%
247,502
-2,972
-1% -$70.2K
MINT icon
18
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$5.86K 0.85%
+51,715
New +$5.21M
JPM icon
19
JPMorgan Chase
JPM
$907B
$5.86K 0.85%
62,282
+438
+0.7% +$41.6K
OSB
20
DELISTED
Norbord Inc.
OSB
$5.8K 0.84%
254,405
-390
-0.2% -$6.71K
T icon
21
AT&T
T
$152B
$5.77K 0.83%
252,949
-5,555
-2% -$127K
INTC icon
22
Intel
INTC
$478B
$5.72K 0.83%
95,661
-25,852
-21% -$1.55M
VIS icon
23
Vanguard Industrials ETF
VIS
$8.12B
$5.7K 0.82%
37,052
-10,240
-22% -$1.25M
GLW icon
24
Corning
GLW
$133B
$5.54K 0.8%
213,703
-549
-0.3% -$12.4K
WRK
25
DELISTED
WestRock Company
WRK
$5.47K 0.79%
193,730
+62,155
+47% +$1.77M

Similar funds

tru Independence's Q2 2020 Portfolio in Review

As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.

tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.

  • tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
  • tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
  • tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
  • tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
  • tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
  • tru Independence opened 207 new positions and closed 53 in Q2 2020.
  • tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.